These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 17543901)
1. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901 [TBL] [Abstract][Full Text] [Related]
2. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function. Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929 [TBL] [Abstract][Full Text] [Related]
4. Ligand-activated PPARδ upregulates α-smooth muscle actin expression in human dermal fibroblasts: A potential role for PPARδ in wound healing. Ham SA; Hwang JS; Yoo T; Lee WJ; Paek KS; Oh JW; Park CK; Kim JH; Do JT; Kim JH; Seo HG J Dermatol Sci; 2015 Dec; 80(3):186-95. PubMed ID: 26481780 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885 [TBL] [Abstract][Full Text] [Related]
8. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1. Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396 [TBL] [Abstract][Full Text] [Related]
13. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868 [TBL] [Abstract][Full Text] [Related]
14. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts. Zhang H; Pi R; Li R; Wang P; Tang F; Zhou S; Gao J; Jiang J; Chen S; Liu P Arch Biochem Biophys; 2007 Apr; 460(1):25-32. PubMed ID: 17346664 [TBL] [Abstract][Full Text] [Related]
15. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha. Pellieux C; Montessuit C; Papageorgiou I; Lerch R Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor {delta} regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-{beta}1/Smad3. Kim HJ; Kim MY; Jin H; Kim HJ; Kang SS; Kim HJ; Lee JH; Chang KC; Hwang JY; Yabe-Nishimura C; Kim JH; Seo HG Circ Res; 2009 Jul; 105(1):16-24. PubMed ID: 19461048 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. Makino N; Sugano M; Satoh S; Oyama J; Maeda T Cell Biochem Biophys; 2006; 44(1):65-71. PubMed ID: 16456235 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands. Jakobsen MA; Petersen RK; Kristiansen K; Lange M; Lillevang ST Scand J Immunol; 2006 May; 63(5):330-7. PubMed ID: 16640656 [TBL] [Abstract][Full Text] [Related]
20. PPARdelta activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway. Lee KS; Park JH; Lee S; Lim HJ; Park HY J Cell Biochem; 2009 Apr; 106(5):823-34. PubMed ID: 19224536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]